Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease
- PMID: 12756103
- DOI: 10.1001/archderm.139.5.651
Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease
Comment on
-
A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.Arch Dermatol. 2003 May;139(5):581-5. doi: 10.1001/archderm.139.5.581. Arch Dermatol. 2003. PMID: 12756094 Clinical Trial.
Similar articles
-
Topical tacrolimus for treatment of childhood vitiligo in Asians.Clin Exp Dermatol. 2004 Nov;29(6):589-92. doi: 10.1111/j.1365-2230.2004.01632.x. Clin Exp Dermatol. 2004. PMID: 15550128 Clinical Trial.
-
Successful treatment of vitiligo with 0.1% tacrolimus ointment.Arch Dermatol. 2003 May;139(5):571-4; discussion 573. doi: 10.1001/archderm.139.5.571. Arch Dermatol. 2003. PMID: 12756092 No abstract available.
-
Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure.Arch Dermatol. 2006 Feb;142(2):252-3. doi: 10.1001/archderm.142.2.252. Arch Dermatol. 2006. PMID: 16490866 No abstract available.
-
[Treatment with tacrolimus in autoimmune diseases].Rev Med Univ Navarra. 2004 Jul-Sep;48(3):24-38. Rev Med Univ Navarra. 2004. PMID: 15622922 Review. Spanish.
-
[Vitiligo--loss of cutaneous pigmentation].Tidsskr Nor Laegeforen. 2006 Sep 21;126(18):2370-2. Tidsskr Nor Laegeforen. 2006. PMID: 16998548 Review. Norwegian.
Cited by
-
Hyperpigmentation in photo exposed patches of vitiligo following tacrolimus therapy.Indian Dermatol Online J. 2014 Apr;5(2):164-6. doi: 10.4103/2229-5178.131090. Indian Dermatol Online J. 2014. PMID: 24860752 Free PMC article.
-
Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.Drugs. 2005;65(6):827-58. doi: 10.2165/00003495-200565060-00011. Drugs. 2005. PMID: 15819596 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical